All In Biotech

NDA 016419 · Baxter Hlthcare Corp

Propranolol Hydrochloride

Propranolol Hydrochloride · Injection

Priority reviewDiscontinued

Last checked: Nov 20, 2026Latest source record: Apr 1, 2008 (newest FDA action)Source: Drugs@FDA, openFDA, CMS, ClinicalTrials.gov, PubMedMethods & limitations

First approved

1967

Nov 13, 1967

Approved uses

1

Original approval plus efficacy supplements

Registered trials

392

63 Phase 3, 46 recruiting

FAERS reports

11,347

7,703 serious, 1,470 with death reported

AI brief across all sources

Written by AI from the FDA, CMS, ClinicalTrials.gov, FAERS and PubMed data on this page, plus web searches for pricing, exclusivity and pending FDA decisions.

What it is approved for

No structured label for this application in openFDA. Older and discontinued products often have none.

Approval history

Original approval and efficacy supplements (new uses, populations or doses), newest first, with FDA's letters and labels.

  • Nov 13, 1967 Original approval · Type 3 - New Dosage Form · priority review
1 products under this application
  • PROPRANOLOL HYDROCHLORIDE · PROPRANOLOL HYDROCHLORIDE 1MG/ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · INJECTABLE, INJECTION · Discontinued

Clinical trials

Interventional ClinicalTrials.gov studies with "Propranolol" as an intervention, any sponsor and status, largest first.

All 392 trials

Most reported adverse reactions

FAERS reports naming this application or brand. Unverified reports, not rates; a report can name several drugs.

Signals
  • off label use1,804
  • drug ineffective1,264
  • nausea919
  • product use in unapproved indication877
  • product use issue869
  • headache797
  • fatigue770
  • toxicity to various agents694
  • diarrhoea624
  • drug intolerance596
  • dyspnoea564
  • dizziness549

FAERS reports by year

By the date FDA received the report.

View as table
YearReports
200499
2005162
2006127
200798
200879
2009153
2010174
2011164
2012203
2013141
2014145
2015149
2016226
2017242
2018371
2019386
2020575
2021873
20221,299
20231,477
20241,873
20251,263
20261,068

Recalls

0 FDA enforcement reports for this application.

No recalls on record for this application.

Shortages

FDA's drug shortage list.

Not on FDA's shortage list.

Medicare spending

CMS Spending by Drug. Part D is pharmacy-dispensed; Part B is given in a clinic or hospital outpatient setting. Spending is before manufacturer rebates.

Compare

Not found under this brand name in Medicare's Part D or Part B Spending by Drug data. CMS lists some drugs under the generic name only.

Published evidence

PubMed clinical trials, meta-analyses and systematic reviews, most relevant first.

All 3,504 on PubMed

Sponsor: Baxter Hlthcare Corp

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.